![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
GlaxoSmithKline |
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00264654 |
This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD)
Condition | Intervention | Phase |
Phobic Disorders |
Drug: BRL29060A Drug: paroxetine hydrochloride hydrate |
Phase III |
MedlinePlus related topics: | Anxiety Phobias |
ChemIDplus related topics: | Paroxetine Paroxetine hydrochloride Paroxetine Mesylate |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Open-Label, Uncontrolled, Long-Term Study- <Phase III Study> |
Enrollment: | 50 |
Study Start Date: | July 2005 |
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Japan | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 144 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 184 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 107 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 194 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 164 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 108 | |||||
GSK Clinical Trials Call Center | |||||
Yokohama-city, Japan, 220 | |||||
GSK Clinical Trials Call Center | |||||
Saitama-city, Japan, 330 | |||||
GSK Clinical Trials Call Center | |||||
Kawaguchi-city, Japan, 332 | |||||
GSK Clinical Trials Call Center | |||||
Tokyo, Japan, 154 |
GlaxoSmithKline |
Study Director: | GSK Clinical Trials, MD | GlaxoSmithKline |
Study ID Numbers: | PIR104777 |
First Received: | December 9, 2005 |
Last Updated: | June 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00264654 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
|
|
|
|
![]() |